These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24386838)

  • 1. [Study on functions of N-carbohydrate chains in human parainfluenza virus type 3 hemagglutinin-neuraminidase protein].
    Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren GJ; Sun CX; Li ZM; Wang ZY
    Bing Du Xue Bao; 2013 Sep; 29(5):500-8. PubMed ID: 24386838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of N-linked glycosylation of the human parainfluenza virus type 3 hemagglutinin-neuraminidase protein.
    Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren GJ; Sun CX; Li ZM; Wang Z
    Virus Res; 2013 Jun; 174(1-2):137-47. PubMed ID: 23562646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid substitutions in leucine zipper motif in the F-specific domain of human parainfluenza virus 3 HN protein play important roles in the protein function.
    Zhang W; Ren G; Wu B; Liu X; Wang G; Song Y; Xu H; Wen H; Wang Z
    Intervirology; 2008; 51(5):311-21. PubMed ID: 19018146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.
    Porotto M; Murrell M; Greengard O; Doctor L; Moscona A
    J Virol; 2005 Feb; 79(4):2383-92. PubMed ID: 15681439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.
    Porotto M; Fornabaio M; Kellogg GE; Moscona A
    J Virol; 2007 Apr; 81(7):3216-28. PubMed ID: 17229690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
    Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
    J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II.
    Palermo LM; Porotto M; Greengard O; Moscona A
    J Virol; 2007 Sep; 81(17):9152-61. PubMed ID: 17567695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN).
    Streltsov VA; Pilling P; Barrett S; McKimm-Breschkin JL
    Antiviral Res; 2015 Nov; 123():216-23. PubMed ID: 26364554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of amino acids at stalk/head interface of human parainfluenza virus type 3 hemagglutinin-neuraminidase protein in the membrane fusion process.
    Jiang J; Wen H; Chi M; Liu Y; Liu J; Cao Z; Zhao L; Song Y; Liu N; Chi L; Wang Z
    Virus Genes; 2018 Jun; 54(3):333-342. PubMed ID: 29516315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oligosaccharide at the C-terminus of the F-specific domain in the stalk of the human parainfluenza virus 3 hemagglutinin-neuraminidase modulates fusion.
    Wang Z; Mirza AM; Li J; Mahon PJ; Iorio RM
    Virus Res; 2004 Feb; 99(2):177-85. PubMed ID: 14749183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo.
    Xu R; Palmer SG; Porotto M; Palermo LM; Niewiesk S; Wilson IA; Moscona A
    mBio; 2013 Oct; 4(5):e00803-13. PubMed ID: 24149514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and mutagenesis of the parainfluenza virus 5 hemagglutinin-neuraminidase stalk domain reveals a four-helix bundle and the role of the stalk in fusion promotion.
    Bose S; Welch BD; Kors CA; Yuan P; Jardetzky TS; Lamb RA
    J Virol; 2011 Dec; 85(24):12855-66. PubMed ID: 21994464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of individual oligosaccharide chains in the activities of the HN glycoprotein of Newcastle disease virus.
    McGinnes LW; Morrison TG
    Virology; 1995 Oct; 212(2):398-410. PubMed ID: 7571409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'a'-Position-mutated and G4-mutated hemagglutinin-neuraminidase proteins of Newcastle disease virus impair fusion and hemagglutinin-neuraminidase-fusion interaction by different mechanisms.
    Chu FL; Wen HL; Zhang WQ; Lin B; Zhang Y; Sun CX; Ren GJ; Song YY; Wang Z
    Intervirology; 2013; 56(1):27-36. PubMed ID: 23038058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposing the flexibility of human parainfluenza virus hemagglutinin-neuraminidase.
    Winger M; von Itzstein M
    J Am Chem Soc; 2012 Nov; 134(44):18447-52. PubMed ID: 23057491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.
    Mishin VP; Watanabe M; Taylor G; Devincenzo J; Bose M; Portner A; Alymova IV
    J Virol; 2010 Mar; 84(6):3094-100. PubMed ID: 20053750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DI-DII linker of human parainfluenza virus type 3 fusion protein is critical for the virus.
    Liu Y; Chi M; Wen H; Zhao L; Song Y; Liu N; Chi L; Wang Z
    Virus Genes; 2020 Feb; 56(1):37-48. PubMed ID: 31768710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of N-linked glycosylation from the hemagglutinin-neuraminidase protein alters virulence of Newcastle disease virus.
    Panda A; Elankumaran S; Krishnamurthy S; Huang Z; Samal SK
    J Virol; 2004 May; 78(10):4965-75. PubMed ID: 15113876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.
    Murrell MT; Porotto M; Greengard O; Poltoratskaia N; Moscona A
    J Virol; 2001 Jul; 75(14):6310-20. PubMed ID: 11413297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).
    Murrell M; Porotto M; Weber T; Greengard O; Moscona A
    J Virol; 2003 Jan; 77(1):309-17. PubMed ID: 12477836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.